Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Trichomoniasis is the most common curable sexually-transmitted infection. Most Trichomonas vaginalis-infect- ed men are asymptomatic and can remain undiagnosed and untreated, and this has been thought to result in chronic persistent prostatic infection. Chronic inflammation is regarded as the major factor in the pathogenesis and progression of benign prostatic hyperplasia (BPH) and prostatic cancer (PCa). The aim of this study is to identify seropositivity to T. vaginalis in men with prostate tumors (BPH or PCa) visited to Hanyang University Hospital. A total of 183 men were en- rolled between October 2013 and November 2014. They consisted of 139 with BPH (mean age: 64.0 ± 0.07) and 44 with prostate cancer (mean age: 73.3±0.18). We carried out ELISA to identify the seropositivity to T. vaginalis. Mixed lysate antigen extracted from 8 strains of T. vaginalis was used in the ELISA. Also 58 male outpatients visited to Health Promo- tion Center in Hanyang University Hospital were evaluated for comparing group. As a results, seropositivity to T. vaginalis in patients with prostatic diseases was 19.7% (BPH: 18.7%, PCa: 22.7%) and it was significantly higher than the 1.7% of the comparing healthy group (P = 0.001). Therefore, prostatic tumor showed higher seropositivity against T. vaginalis than normal men. As far as we know, this is the first report about seroprevalence in prostatic tumor in Korea.
Abstract
Trichomoniasis is the most common curable sexually-transmitted infection. Most Trichomonas vaginalis-infect- ed men are asymptomatic and can remain undiagnosed and untreated, and this has been thought to result in chronic persistent prostatic infection. Chronic inflammation is regarded as the major factor in the pathogenesis and progression of benign prostatic hyperplasia (BPH) and prostatic cancer (PCa). The aim of this study is to identify seropositivity to T. vaginalis in men with prostate tumors (BPH or PCa) visited to Hanyang University Hospital. A total of 183 men were en- rolled between October 2013 and November 2014. They consisted of 139 with BPH (mean age: 64.0 ± 0.07) and 44 with prostate cancer (mean age: 73.3±0.18). We carried out ELISA to identify the seropositivity to T. vaginalis. Mixed lysate antigen extracted from 8 strains of T. vaginalis was used in the ELISA. Also 58 male outpatients visited to Health Promo- tion Center in Hanyang University Hospital were evaluated for comparing group. As a results, seropositivity to T. vaginalis in patients with prostatic diseases was 19.7% (BPH: 18.7%, PCa: 22.7%) and it was significantly higher than the 1.7% of the comparing healthy group (P = 0.001). Therefore, prostatic tumor showed higher seropositivity against T. vaginalis than normal men. As far as we know, this is the first report about seroprevalence in prostatic tumor in Korea.
참고문헌 (23)
- Gardner WA Jr, "Trichomonas vaginalis in the prostate gland", Arch Pathol Lab Med, 110, pp.430~432 (1986)
- Gardner WA Jr, "Subepithelial organisms in trichomonal cervicitis", Diagn Cytopathol, 3, pp.227~229 (1987)
- Grivennikov SI, "Immunity, inflammation, and cancer", Cell, 140, pp.883~899 (2010)
- Gurel B, "Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial", Cancer Epidemiol Biomarkers Prev, 23, pp.847~856 (2014)
- Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections-2008, "World Health Organization", World Health Organization, 1~20 (2012)
- Hobbs MM, "Methods for detection of Trichomonas vaginalis in the male partners of infected women : implications for control of trichomoniasis", J Clin Microbiol, 44, pp.3994~3999 (2006)
- Seña AC1, "Trichomonas vaginalis infection in male sexual partners : implications for diagnosis, treatment, and prevention", Clin Infect Dis, 44, pp.13~22 (2007)
- Skerk V, "The role of unusual pathogens in prostatitis syndrome", Int J Antimicrob Agents, 24, pp.53~56 (2004)
- Mitteregger D, "High detection rate of Trichomonas vaginalis in benign hyperplastic prostatic tissue", Med Microbiol Immunol, 201, pp.113~116 (2012)
- Jong Jin Lee, "PCR for Diagnosis of Male Trichomonas vaginalis Infection with Chronic Prostatitis and Urethritis", Parasites, Hosts and Diseases, 50(2), pp.157~159 (2012), 대한기생충학ㆍ열대의학회[DOI]
- Jun-Hyeok Seo, "Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea", Parasites, Hosts and Diseases, 52(5), pp.551~555 (2014), 대한기생충학ㆍ열대의학회[DOI]
- Sutcliffe S, "Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer", Cancer Epidemiol Biomarkers Prev, 15, pp.939~945 (2006)
- Stark JR, "Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality : physicians’health study", J Natl Cancer Inst, 101, pp.1406~1411 (2009)
- 김규식, "Serum CCL11 Levels in Benign Prostatic Hyperplasia and Prostate Cancer", Urogenital Tract Infection, 11(3), pp.103~108 (2016), 대한요로생식기감염학회
- Ryu JS, "Comparison of three Trichomonas antigens for the detection of IgG antibody in serum", Korean J Clin Microbiol, 3, pp.62~68 (2000)[DOI]
- Shui IM, "Trichomonas vaginalis infection and risk of advanced prostate cancer", Prostate, 76, pp.620~623 (2016)
- Kim SR, "Comparison between mixed lysate antigen and α-actinin antigen in ELISA for serodiagnosis of trichomoniasis", Parasitol Int, 64, pp.405~407 (2015)
- Patel SR, "Systematic review of diagnostic tests for vaginal trichomoniasis", Infect Dis Obstet Gynecol, 8, pp.248~257 (2000)
- Ryu JS, "Diagnosis of trichomoniasis by polymerase chain reaction", Yonsei Med J, 40, pp.56~60 (1999)
- Seo MY, "Inflammatory response of prostate epithelial cells to stimulation by Trichomonas vaginalis", Prostate, 74, pp.441~449 (2014)
- Im SJ, "Inflammatory response of a prostate stromal cell line induced by Trichomonas vaginalis", Parasite immunol, 38, pp.218~227 (2016)
- Kim JH, "Proliferation of prostate stromal cell induced by benign prostatic hyperplasia epithelial cell stimulated with Trichomonas vaginalis via crosstalk with mast cell", Prostate, 76, pp.1431~1444 (2016)
- Sutcliffe S, "Trichomonosis, a common curable STI, and prostate carcinogenesis--a proposed molecular mechanism", PLoS Pathog, 8, pp.e1002801~ (2012)